India Anti-Counterfeit Pharmaceutical Packaging Market Outlook to 2028

India Anti-Counterfeit Pharmaceutical Market Overview

The India anti-counterfeit pharmaceutical packaging market is valued at USD 67 billion, based on a five-year historical analysis. This market is driven by stringent government regulations aimed at curbing the distribution of counterfeit medicines and the increasing consumer demand for secure pharmaceutical products.

Delhi and Mumbai are the dominant cities within the anti-counterfeit pharmaceutical packaging market in India due to their roles as key pharmaceutical manufacturing hubs. These cities house several large-scale pharmaceutical companies, which rely on advanced packaging technologies to ensure the authenticity of their products.

The Indian government amended the Drugs and Cosmetics Act in 2022 to include stricter penalties for counterfeit drug manufacturers. The move is part of the governments broader initiative to curb the circulation of counterfeit medicines and incentivize companies to adopt anti-counterfeit solutions.

India Anti-Counterfeit Pharmaceutical Market Segmentation

By Technology: The market is segmented by technology into RFID, holograms, tamper-evident seals, and barcodes. RFID technology has gained a dominant market share under the segmentation by technology. This is largely due to its ability to provide real-time tracking and verification across the supply chain, reducing the risk of counterfeiting.

By Packaging Format: The market in India is also segmented by packaging format into blister packs, bottles, vials, and sachets. Blister packs hold the largest market share, primarily due to their widespread use in pharmaceutical packaging and their ability to provide both tamper evidence and product protection. Blister packs offer superior visibility and security features, making it easier for manufacturers and consumers to detect tampering.

India Anti-Counterfeit Pharmaceutical Market Competitive Landscape

The market is characterized by the presence of several key players who drive innovation and competition. The market is dominated by large corporations that specialize in secure packaging technologies, along with smaller regional players offering niche solutions.

Company Name

Establishment Year

Headquarters

3M Company

1902

Minnesota, USA

Amcor Limited

1860

Zurich, Switzerland

Du Pont De Nemours, Inc.

1802

Delaware, USA

Avery Dennison Corporation

1935

California, USA

Authentix Inc.

2003

Texas, USA

India Anti-Counterfeit Pharmaceutical Market Analysis

Market Growth Drivers

Stringent Regulatory Measures: Indias Central Drugs Standard Control Organization (CDSCO) has been actively strengthening its regulatory oversight on pharmaceutical products. In 2023, the government mandated QR codes and barcodes on all medicines, allowing for easy authentication. This step was part of a broader effort to ensure the integrity of the pharmaceutical supply chain.

Rise in Counterfeit Drug Incidents India's pharmaceutical industry is grappling with the growing challenge of counterfeit drugs. As per a report by the Ministry of Commerce, over 15% of medicines in circulation are counterfeit, leading to health risks. The Indian pharmaceutical market, being one of the largest globally, faces increasing pressure to implement anti-counterfeiting technologies.

Expanding Pharmaceutical Exports: Indias pharmaceutical export sector has seen robust growth, driven by demand from Africa, Southeast Asia, and the Middle East. In 2023, pharmaceutical exports from India have increased, with authorities emphasizing the importance of anti-counterfeiting measures to maintain quality standards in overseas markets. Countries importing Indian pharmaceuticals are demanding better product tracking systems to ensure the authenticity of imported drugs.

Market Restraints

Fragmented Supply Chain: Indias pharmaceutical supply chain is highly fragmented, with over 10,000 manufacturers and 60,000 distributors, making it difficult to establish uniform anti-counterfeiting protocols. The lack of standardization across the supply chain poses challenges to monitoring and verifying products at every stage.

Limited Awareness Among Rural Consumers: Rural regions in India, where over 600 million people reside, often lack awareness of counterfeit drug risks. This creates a challenge in ensuring the widespread adoption of anti-counterfeit measures, as rural consumers may not prioritize or have access to drug authentication technologies.

India Anti-Counterfeit Pharmaceutical Market Future Outlook

Over the next five years, the India Anti-Counterfeit Pharmaceutical Packaging industry is expected to show growth, driven by stringent regulatory frameworks, advancements in anti-counterfeit technologies, and rising consumer awareness. As counterfeit pharmaceutical products continue to threaten public health and safety, there will be an increasing focus on ensuring the authenticity and security of packaging solutions.

Future Market Opportunities

Widespread Adoption of Blockchain Technology: Over the next five years, blockchain technology is expected to become a standard tool in the fight against counterfeit pharmaceuticals in India. By 2029, nearly all major pharmaceutical companies are projected to adopt blockchain for supply chain transparency, allowing real-time tracking of drug shipments.

Increased Focus on Smart Packaging: By 2029, smart packaging solutions incorporating RFID, QR codes, and digital tags will become ubiquitous across Indias pharmaceutical sector. Smart packaging will enhance consumer confidence by allowing instant verification of a products authenticity. Over the next five years, major pharmaceutical companies are expected to invest heavily in developing tamper-evident packaging and digital verification tools that consumers can easily.
Please Note: It will take 5-7 business days to complete the report upon order confirmation